Bile acid receptor
Also known as: BAR, FXR, HRR1, NR1H4, RIP14
Function
Ligand-activated transcription factor. Receptor for bile acids (BAs) such as chenodeoxycholic acid (CDCA), lithocholic acid, deoxycholic acid (DCA) and allocholic acid (ACA). Plays a essential role in BA homeostasis through the regulation of genes involved in BA synthesis, conjugation and enterohepatic circulation. Also regulates lipid and glucose homeostasis and is involved innate immune response. The FXR-RXR heterodimer binds predominantly to farnesoid X receptor response elements (FXREs) containing two inverted repeats of the consensus sequence 5'-AGGTCA-3' in which the monomers are spaced by 1 nucleotide (IR-1) but also to tandem repeat DR1 sites with lower affinity, and can be activated by either FXR or RXR-specific ligands. It is proposed that monomeric nuclear receptors such as NR5A2/LRH-1 bound to coregulatory nuclear responsive element (NRE) halfsites located in close proximity to FXREs modulate transcriptional activity (By similarity). In the liver activates transcription of the corepressor NR0B2 thereby indirectly inhibiting CYP7A1 and CYP8B1 (involved in BA synthesis) implicating at least in part histone demethylase KDM1A resulting in epigenomic repression, and SLC10A1/NTCP (involved in hepatic uptake of conjugated BAs). Activates transcription of the repressor MAFG (involved in regulation of BA synthesis) (By similarity). Activates transcription of SLC27A5/BACS and BAAT (involved in BA conjugation), ABCB11/BSEP (involved in bile salt export) by directly recruiting histone methyltransferase CARM1, and ABCC2/MRP2 (involved in secretion of conjugated BAs) and ABCB4 (involved in secretion of phosphatidylcholine in the small intestine). Activates transcription of SLC27A5/BACS and BAAT (involved in BA conjugation), ABCB11/BSEP (involved in bile salt export) by directly recruiting histone methyltransferase CARM1, and ABCC2/MRP2 (involved in secretion of conjugated BAs) and ABCB4 (involved in secretion of phosphatidylcholine in the small intestine). In the intestine activates FGF19 expression and secretion leading to hepatic CYP7A1 repression. The function also involves the coordinated induction of hepatic KLB/beta-klotho expression (By similarity). Regulates transcription of liver UGT2B4 and SULT2A1 involved in BA detoxification; binding to the UGT2B4 promoter seems to imply a monomeric transactivation independent of RXRA. Modulates lipid homeostasis by activating liver NR0B2/SHP-mediated repression of SREBF1 (involved in de novo lipogenesis), expression of PLTP (involved in HDL formation), SCARB1 (involved in HDL hepatic uptake), APOE, APOC1, APOC4, PPARA (involved in beta-oxidation of fatty acids), VLDLR and SDC1 (involved in the hepatic uptake of LDL and IDL remnants), and inhibiting expression of MTTP (involved in VLDL assembly. Increases expression of APOC2 (promoting lipoprotein lipase activity implicated in triglyceride clearance). Transrepresses APOA1 involving a monomeric competition with NR2A1 for binding to a DR1 element. Also reduces triglyceride clearance by inhibiting expression of ANGPTL3 and APOC3 (both involved in inhibition of lipoprotein lipase). Involved in glucose homeostasis by modulating hepatic gluconeogenesis through activation of NR0B2/SHP-mediated repression of respective genes. Modulates glycogen synthesis (inducing phosphorylation of glycogen synthase kinase-3) (By similarity). Modulates glucose-stimulated insulin secretion and is involved in insulin resistance. Involved in intestinal innate immunity. Plays a role in protecting the distal small intestine against bacterial overgrowth and preservation of the epithelial barrier (By similarity). Down-regulates inflammatory cytokine expression in several types of immune cells including macrophages and mononuclear cells. Mediates trans-repression of TLR4-induced cytokine expression; the function seems to require its sumoylation and prevents N-CoR nuclear receptor corepressor clearance from target genes such as IL1B and NOS2. Involved in the TLR9-mediated protective mechanism in intestinal inflammation. Plays an anti-inflammatory role in liver inflammation; proposed to inhibit pro-inflammatory (but not antiapoptotic) NF-kappa-B signaling) (By similarity).
Classification
- Family (Pfam)
- PF00104 Hormone_recep, PF00105 zf-C4
- InterPro
- NHR-like_dom_sf, NR_LBD_NR1H4, Nucl_hrmn_rcpt_lig-bd, Nuclear_hormone_rcpt_NR1, Nuclear_hrmn_rcpt, ThyrH_rcpt, Znf_hrmn_rcpt, Znf_NHR/GATA
- Functional cluster
- Zinc-Finger & Chromatin Regulatory Proteins
Experimental structures · PDB · 89
- 1OSH X-ray 1.80A
- 3BEJ X-ray 1.90A
- 3DCT X-ray 2.50A
- 3DCU X-ray 2.95A
- 3FLI X-ray 2.00A
- 3FXV X-ray 2.26A
- 3GD2 X-ray 3.20A
- 3HC5 X-ray 2.60A
- 3HC6 X-ray 3.20A
- 3L1B X-ray 1.90A
- 3OKH X-ray 2.50A
- 3OKI X-ray 2.00A
- … and 77 more
A predicted model is available from AlphaFold.
Gene Ontology · 67
- GO:0000785 chromatin
- GO:0000791 euchromatin
- GO:0016607 nuclear speck
- GO:0005654 nucleoplasm
- GO:0005634 nucleus
- GO:0043235 receptor complex
- GO:0090575 RNA polymerase II transcription regulator complex
- GO:0032052 bile acid binding
- GO:0038186 bile acid nuclear receptor activity
- GO:1902122 chenodeoxycholic acid binding
- GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
- GO:0003700 DNA-binding transcription factor activity
- GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
- GO:0004879 nuclear receptor activity
- GO:0016922 nuclear receptor binding
- GO:0046965 nuclear retinoid X receptor binding
- GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
- GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding
- GO:0043565 sequence-specific DNA binding
- GO:0000976 transcription cis-regulatory region binding
- GO:0001221 transcription coregulator binding
- GO:0008270 zinc ion binding
- GO:0015721 bile acid and bile salt transport
- GO:0030154 cell differentiation
- GO:0007043 cell-cell junction assembly
- GO:1903413 cellular response to bile acid
- GO:0071398 cellular response to fatty acid
- GO:0071222 cellular response to lipopolysaccharide
- GO:0042632 cholesterol homeostasis
- GO:0042742 defense response to bacterium
- GO:0006351 DNA-templated transcription
- GO:0055089 fatty acid homeostasis
- GO:0006954 inflammatory response
- GO:0045087 innate immune response
- GO:0001678 intracellular glucose homeostasis
- GO:0030522 intracellular receptor signaling pathway
- GO:0035356 intracellular triglyceride homeostasis
- GO:0043066 negative regulation of apoptotic process
- GO:0043124 negative regulation of canonical NF-kappaB signal transduction
- GO:0050728 negative regulation of inflammatory response
- GO:0032692 negative regulation of interleukin-1 production
- GO:0032703 negative regulation of interleukin-2 production
- GO:0032715 negative regulation of interleukin-6 production
- GO:0071638 negative regulation of monocyte chemotactic protein-1 production
- GO:0000122 negative regulation of transcription by RNA polymerase II
- GO:0032720 negative regulation of tumor necrosis factor production
- GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway
- GO:0032689 negative regulation of type II interferon production
- GO:0010903 negative regulation of very-low-density lipoprotein particle remodeling
- GO:0038185 nuclear receptor-mediated bile acid signaling pathway
- GO:1904179 positive regulation of adipose tissue development
- GO:2001250 positive regulation of ammonia assimilation cycle
- GO:0045893 positive regulation of DNA-templated transcription
- GO:0046628 positive regulation of insulin receptor signaling pathway
- GO:0035774 positive regulation of insulin secretion involved in cellular response to glucose stimulus
- GO:0032740 positive regulation of interleukin-17 production
- GO:1905695 positive regulation of phosphatidic acid biosynthetic process
- GO:0045944 positive regulation of transcription by RNA polymerase II
- GO:0070857 regulation of bile acid biosynthetic process
- GO:0090181 regulation of cholesterol metabolic process
- GO:0006355 regulation of DNA-templated transcription
- GO:2000211 regulation of glutamate metabolic process
- GO:0061178 regulation of insulin secretion involved in cellular response to glucose stimulus
- GO:0010988 regulation of low-density lipoprotein particle clearance
- GO:0006357 regulation of transcription by RNA polymerase II
- GO:0034162 toll-like receptor 9 signaling pathway
- GO:0019627 urea metabolic process
Disease associations
- cholestasis, progressive familial intrahepatic, 5 MONDO:0014884
Drugs targeting this protein · 9
- URSODIOL agonist
- CHENODIOL agonist
- TERN-101 agonist
- PX-102 agonist
- CILOFEXOR agonist
- NIDUFEXOR agonist
- TROPIFEXOR agonist
- TUROFEXORATE ISOPROPYL agonist
- OBETICHOLIC ACID agonist
Related proteins · sequence + function similarity
- Bile acid receptor 0.99
- Bile acid receptor 0.98
- Bile acid receptor 0.97
- Nuclear receptor ROR-alpha B 0.85
- Nuclear receptor ROR-alpha A 0.82
- Thyroid hormone receptor beta 0.81
- Thyroid hormone receptor alpha-A 0.81
- Thyroid hormone receptor beta 0.81
- Thyroid hormone receptor beta 0.81
- Thyroid hormone receptor beta 0.81
- Oxysterols receptor LXR-alpha 0.81
- Oxysterols receptor LXR-alpha 0.81
Co-cited proteins · studied together in the literature
- Bile acid receptor 13 shared papers
- Fibroblast growth factor 19 2 shared papers
- Bile acid receptor 1 shared papers
- Vitamin D3 receptor 1 shared papers
- Organic solute transporter subunit beta 1 shared papers
- Organic solute transporter subunit alpha 1 shared papers
- Retinoic acid receptor RXR-alpha 1 shared papers
- Vitamin D3 receptor 1 shared papers
- Histone-arginine methyltransferase CARM1 1 shared papers
- Histone H3.2 1 shared papers
- Histone H3.3 1 shared papers
- Histone H3.1 1 shared papers
Literature · 57 cited papers
- Ligand binding and heterodimerization with retinoid X receptor alpha (RXRalpha) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding. J. Biol. Chem. · 2018
- Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis. Nat. Commun. · 2016
- Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Biochem. Pharmacol. · 2013
- SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes. J. Biol. Chem. · 2013
- Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation. Mol. Pharmacol. · 2013
- Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst. Rev. · 2012
- Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms. Biochim. Biophys. Acta · 2012
- Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes. Am. J. Physiol. · 2012
- Farnesoid X receptor represses hepatic human APOA gene expression. J. Clin. Invest. · 2011
- Deciphering the nuclear bile acid receptor FXR paradigm. Nucl. Recept. Signal. · 2010
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut · 2011
- The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett. · 2010
- … and 45 more in the literature graph